When Good Biomarkers Go Bad


In this LabLeaders Webina , you learn more about the role Procalcitonin (PCT) can play in recognizing and managing sepsis as well as the relevant operational features and institutional buy-in necessary to achieve maximum utility from this sepsis marker. Joshua Hayden, PhD, DABCC, FACB as he shares how PCT can help lab leaders bring more value to their labs and learn how to position it to key stakeholders to maximize adoption and clinical utility.

Contributing Lab Leader

Joshua Hayden, PhD

Chief of Chemistry

Norton Healthcare

Other LabLeaders Clinical resources  / 

Other LabLeaders videos and webinars  /